Platelet growth factors - From the laboratory to the clinic

Diáne Hershock, Lynn M. Schuchter

Research output: Contribution to journalReview article

Abstract

Thrombocytopenia can be a life-threatening complication of hematologic disorders or it may be secondary to medical intervention with chemotherapy. The increased use of platelet transfusions to ameliorate the complications of thrombocytopenia carries increased patient risk from platelet transfusions due to alloimmunization, infection, and transfusion reactions. Recent advances in the understanding of platelet growth factors, including thrombopoietin, interleukin (IL)-3, IL-6, and IL-11 have shown that their clinical use may decrease platelet-transfusion requirements.

Original languageEnglish (US)
Pages (from-to)183-189
Number of pages7
JournalInfections in Medicine
Volume16
Issue number3
StatePublished - Jan 1 1999

Fingerprint

Platelet Transfusion
Intercellular Signaling Peptides and Proteins
Blood Platelets
Thrombocytopenia
Interleukin-11
Thrombopoietin
Interleukin-3
Interleukin-6
Drug Therapy
Infection

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Hershock, Diáne ; Schuchter, Lynn M. / Platelet growth factors - From the laboratory to the clinic. In: Infections in Medicine. 1999 ; Vol. 16, No. 3. pp. 183-189.
@article{c20d5b8f6ccb4276b0a35a1ee2f3a41d,
title = "Platelet growth factors - From the laboratory to the clinic",
abstract = "Thrombocytopenia can be a life-threatening complication of hematologic disorders or it may be secondary to medical intervention with chemotherapy. The increased use of platelet transfusions to ameliorate the complications of thrombocytopenia carries increased patient risk from platelet transfusions due to alloimmunization, infection, and transfusion reactions. Recent advances in the understanding of platelet growth factors, including thrombopoietin, interleukin (IL)-3, IL-6, and IL-11 have shown that their clinical use may decrease platelet-transfusion requirements.",
author = "Di{\'a}ne Hershock and Schuchter, {Lynn M.}",
year = "1999",
month = "1",
day = "1",
language = "English (US)",
volume = "16",
pages = "183--189",
journal = "Infections in Medicine",
issn = "0749-6524",
publisher = "CMP Healthcare Media LLC",
number = "3",

}

Platelet growth factors - From the laboratory to the clinic. / Hershock, Diáne; Schuchter, Lynn M.

In: Infections in Medicine, Vol. 16, No. 3, 01.01.1999, p. 183-189.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Platelet growth factors - From the laboratory to the clinic

AU - Hershock, Diáne

AU - Schuchter, Lynn M.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Thrombocytopenia can be a life-threatening complication of hematologic disorders or it may be secondary to medical intervention with chemotherapy. The increased use of platelet transfusions to ameliorate the complications of thrombocytopenia carries increased patient risk from platelet transfusions due to alloimmunization, infection, and transfusion reactions. Recent advances in the understanding of platelet growth factors, including thrombopoietin, interleukin (IL)-3, IL-6, and IL-11 have shown that their clinical use may decrease platelet-transfusion requirements.

AB - Thrombocytopenia can be a life-threatening complication of hematologic disorders or it may be secondary to medical intervention with chemotherapy. The increased use of platelet transfusions to ameliorate the complications of thrombocytopenia carries increased patient risk from platelet transfusions due to alloimmunization, infection, and transfusion reactions. Recent advances in the understanding of platelet growth factors, including thrombopoietin, interleukin (IL)-3, IL-6, and IL-11 have shown that their clinical use may decrease platelet-transfusion requirements.

UR - http://www.scopus.com/inward/record.url?scp=0033012897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033012897&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0033012897

VL - 16

SP - 183

EP - 189

JO - Infections in Medicine

JF - Infections in Medicine

SN - 0749-6524

IS - 3

ER -